Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
Forum: Medical Device Single Use Disposables
Register View Registrations Tell a Friend About This EventTell a Friend
 

 Export to Your Calendar 11/1/2017
When: Wed Nov 1, 2017
5:30-8:30 PM
Where: Regis College, Fine Arts Center
235 Wellesley St
Weston, Massachusetts  02493
United States
Contact: Bill Munger
617-620-4161


Online registration is available until: 11/1/2017
« Go to Upcoming Event List  


Nov 1 MDG Forum

Medical Device Single Use Disposables 
   

Success in the development and manufacture of single use medical disposables requires thoughtful design with manufacturing in mind, and use of technology and scaling plans that take full advantage of the latest low cost manufacturing methods and in many cases, automation techniques. 
 


  • $44B in US annual sales
  • Both single use low volume and high volume disposables
  • Entire product or components
  • Requires thoughtful design & careful execution - learn how it is done at this MDG Boston forum
    


Wednesday Nov 1, 5:30 - 8:30 PM
Regis College Fine Arts Center
Weston, MA

Member  - $30
Non-Member - $40
Student - $15

Who Should 
  • Scientists, Engineers, Managers to better develop disposables
  • Entrepreneurs  seeking ways to make their ideas fundable and profitable
  • Physicians and Clinical professionals needing a team to translate a disposable idea into commercial reality
  • Professionals  seeking opportunities in the medical disposable market
Our Distinguished Pan
Moderator
Panelists

 






Rahul Dhanda, Sr. VP, Corporate Development & Marketing, T2 Biosystems

Jon McIntyre, VP of Product Development, 
BridgeMedica
 

Chris Nother, VP of Business Development, Nypro Healthcare

Steven Zappala, MD, FACS, Chief Medical Officer at OPKO Urology, Founder of Andover Urology

Mike Magliochetti
Ph.D., M.B.A., Operating Partner,
Riverside Partners

Program Description
The overall disposable medical device consumable industry represents over $44 B in revenue in the US alone.   Single use disposables devices are critical components of many medical  device business models, either as a standalone consumable that is the entire product  (e.g. syringes, lateral flow immunoassay kits, cardiac catheters) or that are part of a razor/razor blade model (e.g. Diagnostic cartridge and reader, ventilator breathing circuit, infusion pump / pump set). These devices can range from very specialized single use micro-fluidic devices to high volume, high quality disposables.   

Success in the development and manufacture of single use medical disposables requires thoughtful design with manufacturing in mind, and use of technology and scaling plans that take full advantage of the latest low cost manufacturing methods and in many cases, automation techniques.   

This panel will describe the various approaches in the development of single use medical device disposables as well as the need to address regulatory, reimbursement, design process and the techniques of scaling with volume.  Case studies will also provide examples of a successful design scale and launch processes.

Panel Bios
Moderator
Rahul DhandaSenior VP, Corporate Development & Marketing, T2 Biosystems
Rahul Dhanda is the Senior VP of Corporate Development & Marketing since February 2016. He joined T2 Biosystems in January 2008 and has held several leadership roles including Vice President of Marketing since 2010. Prior to joining T2 Biosystems, Rahul worked in marketing at Boston Scientific's Urology division, where he led the team responsible for the Access, Visualization and Laser Lithotripsy franchises, representing roughly $100 million in annual revenue. Prior to Boston Scientific, Rahul worked in business development at Interleukin Genetics, where he helped negotiate the firm's acquisition by Alticor, Inc. as well as multiple other deals. Rahul earned his M.B.A. from MIT's Sloan School of Management and his B.A. from Wesleyan University. He is a former committee member of the AAAS Committee on Scientific Freedom and Responsibility. Rahul is the author of several publications, an inventor on numerous patents and applications, and has authored the first book to address the crossroads between industry and bioethics/public policy, entitled Guiding Icarus: Merging Bioethics with Corporate Interests.

Speakers    
Jon McIntyreVP of Product Development, BridgeMedica
An accomplished medical device industry professional with over 30 years of leadership and product development experience. Jon is one of the founding employees of Bridgemedica, where he is responsible for a cross-disciplinary team of product development engineers. His project management and engineering skills have led to numerous successful PMA and 510(k) product launches. Jon has developed products in the fields of Ophthalmology, Women's Health/Surgical Gynecology, Electrophysiology, Urology, Neurosurgery, Oncology, General Surgery, and Interventional Cardiology. Jon holds 35 issued U.S. patents with approximately 30 additional pending patent applications. He has co-authored several publications and scientific abstracts. Jon earned a BS in Mechanical Engineering from Northeastern University. Prior to Bridgemedica, his previous employers included Boston Scientific, CardioFocus and CR Bard.

Chris NotherVP of Business Development, Nypro Healthcare
Chris heads up Business Development at the Pharma Delivery Solutions (PDS) division of Nypro Healthcare. He is a Business and Economics graduate of Trinity College, Dublin and has almost thirty years' business experience in investment banking, print & packaging, plastics and in medical devices - in business development, CEO, M&A and entrepreneurial roles. Chris has been with Nypro for 14 years. Nypro's PDS division is the world's leading contract development and manufacturing organisation for combination drug delivery devices, supporting Big Pharma, Generics, Biotechs and Start-Ups alike. With over 600 million devices shipped to and on behalf of clients every year, across inhalation and injection delivery platforms, there are very few people on the planet who have not been touched by a device manufactured by Nypro.
   
Stephen M. Zappala, M.D., FACSChief Medical Officer at OPKO Urology, Founder of Andover Urology
He is a Board Certified Diplomate of the American Board of Urology specializing in pediatric and adult urologic surgery. He is founder of Andover Urology and has obtained over 15 United States patents on a variety of medical instruments and devices. He received the American Transplant Society-Upjohn Corporation: Young Investigator Award in 1995. In 2003, he was elected to the Best Doctors of America and lectures nationally and internationally on Biomarkers in Prostate Cancer. Dr. Zappala previously served as Chief Medical Officer at OPKO Urology where he currently serves as Senior Corporate-Medical Liason. He is on the Medical Advisory Boards at Riverside Capital, Boston MA, and Cellanyx Bioventures, and is President of MICA Medical. He practices Urology at the Massachusetts General Hospital: Andover as Clinical Assistant Professor of Urology, Harvard Medical School.
He received a B.S. from Boston College and M.D. from University of Massachusetts Medical School, Worcester, MA. He completed a residency in Internal Medicine at University of Massachusetts, Worcester, and Urologic residencies at UCLA and UMASS Medical Center, and fellowship training in Pediatric Urology at the Hospital for Sick Children, London, England.  

Mike Magliochetti, Ph.D., M.B.A.Operating Partner, Riverside Partners
Mike is an Operating Partner with Riverside Partners, LLC, a leading private equity firm focused on investing in middle market healthcare and technology companies. He previously served as President and CEO of OPKO Diagnostics, LLC, a point-of-care in-vitro diagnostic firm and wholly owned subsidiary of OPKO Health, Inc. (OPK:NYSE).  Dr. Magliochetti executed the sales transaction of Claros Diagnostics, where he was serving as CEO, to OPKO at a premium valuation. He has served as CEO in a number of other companies, including RMH, HemaMetrics, and Urosurge. He currently serves on the boards of many other medical technology companies. He holds several patents, has authored numerous technical and business publications, served on many professional panels, and has lectured at universities in the U.S. and internationally on entrepreneurship and business development. Dr. Magliochetti holds B.S. and Ph.D. degrees in Chemical Engineering from Northeastern University and the University of Massachusetts at Amherst, respectively, and a High Technology M.B.A. from Northeastern University.

Agenda
5:30 - 6:15PM Arrival, Networking & Dinner
6:15 - 6:30PM Announcements and Introductions
6:30 - 8:00PM Speakers and Q&A

    1) Moderator Introduction - Rahul Dhanda, T2 Biosystems

    2) Design Considerations for Manufacturability and Automation - Jon McIntyre, BridgeMedica

    3) Entrepreneurial approaches to design and scale up, quality and development of single use medical device disposables -           Chris Nother, Nypro and Steven Zappala, MD  

    4) Case study of successful launch of a consumable - Mike Magliochetti, Riverside Partners

8:00 - 8:30PM More networking

Program Co-Chairs



Hank Allard
MDGBoston VP and Director;
Edge Business Associates  broker
Doug Lawrence
MedTech CEO | General Manager | Medical Products Marketer
Paul Sabin
Principal, Fikst Product Development

Fees 
Fees 
(Light dinner included)
Registration Fee: Early Reg.
(By Oct 25)
Week Prior
(Oct 25 - Nov 1)

At the Door
(Nov 1
 
Members: $30 $35 $40
NonMembers: $40 $47  $55
Students with a Valid ID $15  $15  $15 

      
Location (Free Parking)

Regis College, Fine Arts Center
235 Wellesley St, Weston, MA 02493
   
  
About MDG
The Medical Development Group (MDG) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care. MDG pursues this mission through the organization of educational programs and forums: the facilitation of cross-disciplinary dialogue and collaboration; the creation of venues for networking and information sharing for current and aspiring professionals, clinicians, and entrepreneurs; and the development of alliances with complementary organizations.

more MDG Calendar

10/4/2017
Forum: Augmented and Virtual Reality - From Games to Game Changing Developments

10/6/2017 » 10/8/2017
MEMBERS ONLY-Harvard Business School 2017 ""Educating the Global Health Innovator" GENiE Conference

MDG Premium & Annual Sponsors

 CONTACT


 Medical Development  Group
 POB 555
 Concord, MA 01742

 

 Email:

 MDGBoston@gmail.com

 NAVIGATION 

 

Home

  

 About Us
 Terms of Use
 Privacy Policy

PREMIUM SPONSOR

 

 

   

PREMIUM SPONSOR

 

Association Management Software Powered by YourMembership  ::  Legal